biomarkerstrategies.org biomarkerstrategies.org

BIOMARKERSTRATEGIES.ORG

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

http://www.biomarkerstrategies.org/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR BIOMARKERSTRATEGIES.ORG

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

July

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.8 out of 5 with 11 reviews
5 star
3
4 star
5
3 star
2
2 star
0
1 star
1

Hey there! Start your review of biomarkerstrategies.org

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

6.5 seconds

FAVICON PREVIEW

  • biomarkerstrategies.org

    16x16

  • biomarkerstrategies.org

    32x32

  • biomarkerstrategies.org

    64x64

  • biomarkerstrategies.org

    128x128

CONTACTS AT BIOMARKERSTRATEGIES.ORG

BioMarker Strategies

855 N.Wol●●●●●●●●●Suite 603

Bal●●●ore , MD, 21205

US

1.41●●●●1008
1.41●●●●1009
no●●●●●●●●●●●●@worldnic.com

View this contact

BioMarker Strategies

855 N.Wol●●●●●●●●●Suite 603

Bal●●●ore , MD, 21205

US

1.41●●●●1008
1.41●●●●1009
no●●●●●●●●●●●●@worldnic.com

View this contact

BioMarker Strategies

855 N.Wol●●●●●●●●●Suite 603

Bal●●●ore , MD, 21205

US

1.41●●●●1008
1.41●●●●1009
no●●●●●●●●●●●●@worldnic.com

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
n/a
UPDATED
2012 December 12
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

NAME SERVERS

1
ns5.worldnic.com
2
ns6.worldnic.com

REGISTRAR

Network Solutions, LLC (R63-LROR)

Network Solutions, LLC (R63-LROR)

WHOIS : whois.publicinterestregistry.net

REFERRED :

CONTENT

SCORE

6.2

PAGE TITLE
BioMarker Strategies Homepage | biomarkerstrategies.org Reviews
<META>
DESCRIPTION
BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.
<META>
KEYWORDS
1 snappath
2 ex vivo
3 our pathmap
4 biomarker strategies
5 info@biomarkerstrategies com
6 recent headlines
7 2017 biomarker strategies
8 coupons
9 reviews
10 scam
CONTENT
Page content here
KEYWORDS ON
PAGE
snappath,ex vivo,our pathmap,biomarker strategies,info@biomarkerstrategies com,recent headlines,2017 biomarker strategies
SERVER
Microsoft-IIS/8.5
POWERED BY
ASP.NET
CONTENT-TYPE
iso-8859-1
GOOGLE PREVIEW

BioMarker Strategies Homepage | biomarkerstrategies.org Reviews

https://biomarkerstrategies.org

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

INTERNAL PAGES

biomarkerstrategies.org biomarkerstrategies.org
1

BioMarker Strategies Homepage

http://www.biomarkerstrategies.org/index.html

BioMarker Strategies has developed the proprietary and recently patented SnapPath Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. SnapPath is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. Presentation by B...

2

PathMap @ BioMarker Strategies

http://www.biomarkerstrategies.org/pathmap.html

PathMap Functional Signaling Profiles. Profiles reveal information regarding signal transduction networks, including pathway activation and feedback loops, that predict patient response to targeted drug therapy. Enabled by the SnapPath. Is an enabling platform for this new class of biomarkers, including ex vivo-based companion diagnostics. Much of the early work in ex vivo biomarkers was pioneered in leukemia and lymphoma. BioMarker Strategies has extended this work to solid tumors using the SnapPath.

3

Leadership @ BioMarker Strategies

http://www.biomarkerstrategies.org/leadership.html

Greg Bertenshaw, PhD. Vice President, Research and Development. Chairman and Director;. Co-Founder and Former Chairman and CEO, Dianon Systems. Glenn Miller, PhD. Chair of the Scientific Advisory Board and Director; Former Chief Technology Officer and Executive Vice President, MolecularMD. Chairman and Director;. Co-Founder and Former Chairman and CEO, Dianon Systems. Director, Co-Founder and Former President; President, SJA Healthcare Strategies. Douglas P. Clark,. Glenn Miller, PhD. Dr Greg Bertenshaw,.

4

SnapPath Platform @ BioMarker Strategies

http://www.biomarkerstrategies.org/system.html

BioMarker Strategies developed the proprietary SnapPath Cancer Diagnostics System*. To guide targeted drug development and treatment selection for patients with solid tumor malignancies. Is the only diagnostics system able to generate purified populations of live solid tumor cells from fresh, unfixed samples in a rapid and standardized manner. SnapPath preserves the molecular integrity of these live cells for. The PathMAP Functional Signaling Profiles enabled by the SnapPath System provide direct informa...

5

Investors and Strategic Partners @ BioMarker Strategies

http://www.biomarkerstrategies.org/investors.html

BioMarker Strategies is a privately held, Maryland-based limited-liability company located in Rockville, Maryland. To date, the company has been funded by private investors, including the Abell Foundation. BioMarker Strategies has also been awarded approximately $5m in non-dilutive funding from the National Cancer Institute to develop the SnapPath. Platform, including a recent $1.5m Phase II SBIR award to develop a predictive diagnostic test for advanced melanoma patients.

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL PAGES IN THIS WEBSITE

7

OTHER SITES

biomarkerstore.net biomarkerstore.net

Web Page Under Construction

This Site Is Under Construction and Coming Soon. This Domain Is Registered with Network Solutions.

biomarkerstrategies.biz biomarkerstrategies.biz

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

biomarkerstrategies.com biomarkerstrategies.com

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

biomarkerstrategies.info biomarkerstrategies.info

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

biomarkerstrategies.net biomarkerstrategies.net

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

biomarkerstrategies.org biomarkerstrategies.org

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

biomarkerstrategies.us biomarkerstrategies.us

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

biomarkersusa-congress.com biomarkersusa-congress.com

Biomarkers & Precision Medicine USA Congress, 3-4 October 2016, San Diego , USA

2nd Annual Biomarkers and Precision Medicine USA Congress. 9-10 October 2017, San Diego, USA. View Free Webinar Programmes. An Example of Delegate Attendance. 2016 Speaker Line Up. Q & A. 2017 Biomarkers USA Sponsors. White Papers & Product Announcements. View Free Webinar Programmes. An Example of Delegate Attendance. 2016 Speaker Line Up. Q & A. 2017 Biomarkers USA Sponsors. White Papers & Product Announcements. 2nd Annual Biomarkers & Precision Medicine USA Congress 2017. October 2017, San Diego, USA.

biomarkertechnologies.com biomarkertechnologies.com

biomarkertechnologies.com -&nbspThis website is for sale! -&nbspdrug biotech pharmaceutical Resources and Information.

The domain biomarkertechnologies.com. May be for sale by its owner! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.

biomarkertechnology.com biomarkertechnology.com

biomarkertechnology.com -&nbspThis website is for sale! -&nbspdrug biotech pharmaceutical Resources and Information.

The domain biomarkertechnology.com. May be for sale by its owner! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.

biomarkertest.com biomarkertest.com

www.biomarkertest.com